Background-L-Arginine has been shown to induce fluid secretion in human jejunum. Nitric oxide, a derivative of L-arginne is thought to have an important role as an intestinal secretagogue. Aim-To determine the effect of Larginine and the nitric oxide synthase inhibitor, nitro L-arginine methyl ester (L-NAME), on fluid and electrolyte movement in rat jejunum. Methods-A 25 cm segment ofrat jejunum was perfused in situ with iso-osmotic solutions containing either (1) saline, (2) D-arginine 20, (3) L-arginine 20, (4) L-NAME 0-1, 1, or 20 mmol/l, or (5) a combination of L-arginine 20 and L-NAME 0.1, 1, or 20 mmol/l. In further groups the effect of a subcutaneous injection of L-NAME 100 mglkg was examined in rats pretreated with either Dor L-arginine 500 mg/kg. Results-L-Arginine, unlike D-arginine, induced fluid secretion despite being better absorbed (mean -7 3 v 17-0 ,l/min/ g; p<001). L-NAME at 0.1 mmol/l had no effect on basal fluid movement but reversed L-arginine induced secretion (7.8; p<005). L-NAME at 1 and 20 mmol/l induced fluid secretion (-15.4 and -28-4, respectively), which was enhanced by the addition of L-argilnlne (-30.0 and -41-0, respectively; both p<005). A subcutaneous injection of L-NAME resulted in marked fluid secretion (-39.9) and histological evidence of intestinal ischaemia. These changes were attenuated or reversed by pretreatment with subcutaneous L-but not D-arginine. Conclusions-L-Arginine induces intestinal fluid secretion through production of nitric oxide. There is a delicate balance between the effect of nitric oxide as a secretagogue and its effect on maintaining blood flow and thus preventing intestinal ischaemia. (Gut 1996; 39: 539-544) Keywords: arginine, nitric oxide, L-NAME, intestinal transport, bowel ischaemia.
Abstract
Background-L-Arginine has been shown to induce fluid secretion in human jejunum. Nitric oxide, a derivative of L-arginne is thought to have an important role as an intestinal secretagogue. Aim-To determine the effect of Larginine and the nitric oxide synthase inhibitor, nitro L-arginine methyl ester (L-NAME), on fluid and electrolyte movement in rat jejunum. Methods-A 25 cm segment ofrat jejunum was perfused in situ with iso-osmotic solutions containing either (1) saline, ( 2) D-arginine 20, (3) L-arginine 20, (4) L-NAME 0-1, 1, or 20 mmol/l, or (5) a combination of L-arginine 20 and L-NAME 0.1, 1, or 20 mmol/l. In further groups the effect of a subcutaneous injection of L-NAME 100 mglkg was examined in rats pretreated with either Dor L-arginine 500 mg/kg. Results-L-Arginine, unlike D-arginine, induced fluid secretion despite being better absorbed (mean -7 3 v 17-0 ,l/min/ g; p<001). L-NAME at 0.1 mmol/l had no effect on basal fluid movement but reversed L-arginine induced secretion (7.8; p<005) . L-NAME at 1 and 20 mmol/l induced fluid secretion (-15.4 and -28-4, respectively), which was enhanced by the addition of L-argilnlne (-30 .0 and -41-0, respectively; both p<005). A subcutaneous injection of L-NAME resulted in marked fluid secretion (-39.9 ) and histological evidence of intestinal ischaemia. These changes were attenuated or reversed by pretreatment with subcutaneous L-but not D-arginine. Conclusions-L-Arginine induces intestinal fluid secretion through production of nitric oxide. There is a delicate balance between the effect of nitric oxide as a secretagogue and its effect on maintaining blood flow and thus preventing intestinal ischaemia.
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Actively transported sugars and most amino acids enhance small intestinal absorption of water and electrolytes.l`However, L-arginine (L-Arg), unlike other amino acids, has been shown by us and others to induce water secretion when perfused in human jejunum.' 5 A satisfactory explanation has never been put forward to explain this phenomenon, though it has been suggested that L-Arg induced secretion by a local effect that could be inhibited by the calmodulin antagonist chlorpromazine. 5 Over the past few years L-Arg has been found to be the precursor of the free radical nitric oxide (NO), which has an important role as a mediator of neural, cardiovascular, and gastrointestinal function.`8 Nitric oxide is derived from the guanidino terminal of L-Arg by the action of the stereospecific enzyme nitric oxide synthase (NOS) which, in the gut, is present in the myenteric plexus9 10 and submucosal arterioles and venules."' 12 In addition, it has been shown that NO could be produced by enterocytes through both the constitutive and the inducible NOS." In vitro studies have unveiled a role for NO as a secretagogue in the ileum14 '5 and colon, [16] [17] [18] and in vivo studies have suggested a possible role for NO in the laxative action of castor oil,"9 magnesium sulphate,20 and in the pathophysiology of secretion induced by Escherichia coli heat stable enterotoxin.`5 In addition, NO is a vasodilator and its continuous endogenous production is important in maintaining gastric microcirculation and mucosal integrity.2' 22 However, the effect of endogenous NO on small intestinal water absorption/secretion and mucosal integrity is unknown. The aim of this study was to examine (a) the pathophysiology of L-Arg induced jejunal secretion and its relation with NO production, and (b) the structural and functional effects of NOS inhibition in rat jejunum by examining the water and electrolyte movement and the histological changes in the jejunum after administration of the NOS inhibitor nitro L-arginine methyl ester (L-NAME).
Methods
In vivo perfusion model Male adult Wistar rats (180-220 g body weight) were fasted for 18 hours with free access to water. The rats were anaesthetised by intraperitoneal injection of sodium pentobarbitone (60 mg/kg) and maintained throughout the experiment by interval intraperitoneal injections (1 5-30 mg/kg) as necessary. The abdomen was opened through a midline incision and a 25 cm segment of jejunum Effect of L-NAME on water and electrolyte transport in ratjejunum
Intestinal perfusion was performed in six groups of animals with solutions containing the NOS inhibitor, L-NAME at concentrations of 0O1, 1, or 20 mmol/l with or without L-Arg 20 mmolIl (Table I ). The solutions were perfused for 30 minutes to reach steady state and then three collections of the effluent of 10 minutes each were collected.
To study the effect of systemic L-NAME, three groups of animals were injected subcutaneously with either L-Arg or D-Arg 500 mg/kg in 0.3 ml saline, or 0.3 ml saline alone, followed after 15 minutes by subcutaneous L-NAME 100 mg/kg in 0.3 ml saline. After a further 20 minutes jejunal perfusion with an iso-osmotic saline solution was performed.
Analytical methods
['4C]PEG concentrations in the effluent were measured in triplicate by liquid scintillation spectroscopy in LKB Wallac Ultra-beta 1210 scintillation counter. Sodium and potassium concentrations were determined by flame photometry (Instrument Laboratories 943), and chloride concentration by Coming 925 chloride analyser (Coming, UK). Solution osmolality was analysed using the vapour pressure technique with a Wescor 5500 osmometer. L-Arg and D-Arg concentrations in the effluent were measured by the colorimetric method of Sakagushi as previously described. 24 25 In brief, 0.5 ml of sample solution and 0.5 ml of 20% potassium hydroxide were mixed in a test tube colled in an ice-water bath. Acetic anhydride (0.075 ml) was added and the tube shaken vigorously in the ice. One hour later 0.5 ml of 0.01% l-naphthol in 10% potassium hydroxide solution was added followed by 0.2 ml of 0.06% hypobromite solution. This was followed by 0.5 ml of alcohol and one hour later a second addition of 0.2 ml of hypobromite solution was made. The optical density was measured at 520 nm and compared with that of known concentrations of Arg. The net water, electrolyte, and Arg movement was calculated and expressed respectively in ,ul/min/g and ,moUmin/g of dry intestinal weight. Positive values denote absorption and negative values denote secretion.
Histology
Jejunal sections were stained with haematoxylin and eosin and histology was evaluated by a pathologist unaware of the experimental protocol from which the tissue originated. 
Results
Effect of the NO precursor, L-Arg on water and electrolyte transport Perfusion of rat jejunum with an iso-osmotic saline solution (Fig 1A) resulted in a mean (SEM) net water absorption of 18 3 (3 6) ,uA/min/g dry intestinal weight, whereas 20 mmol/l of L-Arg caused water secretion (-7 3 (2-6); p<00000l compared with saline). This phenomenon was not observed with D-Arg where net water absorption (17-0 (9 0)) was not different from the saline control, but significantly different from the L-Arg (p<0 05) (Fig 1A) . Likewise, sodium and chloride absorption were greater with saline solution than with L-Arg containing solution ( Figs 1B  and 1C) . Paradoxically, D-Arg resulted in a decrease in chloride absorption than saline ( Fig  1C) . Absorption of L-Arg was greater than its D-enantiomer (9-8 (2 0) Fmolmin/g v 2-2 (0-5); p<001).
Subcutaneous administration of L-Arg or D-Arg in a dose of 100 or 500 mg/kg had no effect on water (Fig 2) Effect ofNOS inhibition with L-NAME The NOS inhibitor L-NAME perfused intraluminally in a concentration of 0-1 mmolI had no effect on water and electrolyte movement, but in higher doses of 1 and 20 mmolI it led to water secretion (Fig 3) and to a marked decrease or reversal of electrolyte absorption (Table II) . Perfusion with combinations of L-NAME and L-Arg (Fig 3) showed that L-NAME at a concentration of 0-1 mmolI reversed L-Arg induced secretion to absorption. At the higher concentrations of L-NAME (1 and 20 mmol/l), however, L-Arg induced secretion was enhanced rather than reversed (Fig 3) .
All intestinal segments perfused with L-NAME at 1 and 20 mmol/l with or without L-Arg appeared grossly dusky and ischaemic but there were no obvious abnormalities on light microscopy.
A subcutaneous injection of L-NAME (100 mg/kg) 20 minutes before starting the jejunal perfusion caused severe intestinal secretion (-39 9 (5 4)) (Fig 4) . Pretreatment with L-Arg (500 mg/kg) subcutaneously, partially but significantly attenuated the secretory response. D-Arg had no effect on L-NAME induced intestinal secretion (Fig 4) . Sodium and chloride movement paralleled that of water (Table II) .
Intestinal segments perfused after L-NAME injection showed marked macroscopic changes; the intestine looked ischaemic with obvious areas of infarction. Microscopically, there were typical histological changes of ischaemia with :hL-Arg+L-NAME 1. ment could be due to the ability of NO to Ld L-Arg+L-NAME 1. stimulate soluble guanylate cyclase resulting in L-Arg+L-NAME 20. nd L-Arg+L-NAME 20.
the production of the second messenger cyclic 26 GMP, a potent prosecretory agent. L-NAME L-Arg + D-Arg + however, L-NAME at a concentration of 1 and (n 10) L-NAME i-NAME 20 mmol/l given alone caused secretion in the rat jejunum and enhanced rather than reversed e 4: Water movement in ratjejunum perfused with an water secretion induced by L-Arg, which may motic saline solution after a subcutaneous injection of [ME 100 mg/kg alone, or after pretreatment with imply that these substances induce water taneous L-Arg or D-Arg 500 mg/kg. Values are secretion by different mechanisms. The effects ssed as mean (SEM). Positive values denote of L-NAME at higher doses are more difficult ption and negative values denote secretion. ANOVA 91; *p<0.01 compared with L-NAME and with to explain. The effect of L-NAME on itestial + L-NAME.
water transport in previous studies has been conflicting. Miller et al found that administration of L-NAME orally to guinea pigs for nucosal oedema and haemorrhages with seven days resulted in ileal water secretion. 27 degenerative changes of the surface Rolfe and Levin showed that L-NAME helium at the tip of villi (Fig 5) . All these administration in rats by the intraperitoneal iges were prevented by pretreatment with route in a dose of 40 mg/kg reversed Escherichia .g (Fig 5B) but not D-Arg.
coli heat stable toxin (Sta) induced secretion to absorption, implying that NO is a secretagogue'5; however Schirgi-Degen and Beubler cussion found that intravenous L-NAME adminisno acids are actively transported in the tration led to net fluid secretion in rat jejunum [ 1 intestine and in general enhance water and enhanced Sta secretion, concluding that electrolyte absorption.' 3 4 However, the NO has a proabsorptive role in the intestine.28
Lsic amino acid L-Arg has been shown to In these studies intestinal ischaemia and hisice water secretion in human jejunum.' 5 tology were not evaluated. ilarly, in our experiments we have shown Our studies suggest that there is a fine L-Arg induced water secretion when per-balance between the direct secretory effect d in rat jejunum (Fig 1) . This phenomenon of NO on enterocytes or via prosecretory ereospecific and not osmotically driven as neurones and its role in maintaining intestinal 30 and therefore NO and other nitrogen oxides could stimulate secretion by the nature of their free radical structure. L-NAME is absorbed from the small intestine and Gardiner et al have found a 25% decrease in mesenteric blood flow in rats drinking a solution containing 0. 1 mg/ ml L-NAME.3' We would expect the highest concentration and the total amount of L-NAME administered in our experiments would cause a significant fall in mesenteric blood flow. With perfusions of L-NAME at 1 and 20 mmol/l the intestine was clearly ischaemic, though not severely enough to cause histological changes. This may be due to the fact that histological changes usually appear within 30 minutes to one hour after total circulatory arrest to the intestine, 32 36 The concentration of L-NAME required to reverse L-Arg induced secretion in our study was low compared with previous studies, where the dose of L-Arg able to counteract the L-NAME effect can be threefold to 100-fold higher than that of the NOS inhibitor depending on tissues and species.37 This could be explained by the fact that L-NAME may be better absorbed than L-Arg, or the concentration of NO needed to activate secretion either directly or through neuronal reflexes is much lower than that required for vasodilatation. Although L-NAME has been found to have an antimuscarinic effect,38 it is unlikely that it has an important role in our experiments as the antimuscarinic effect is independent of NO production and thus it would not be antagonised by the NO precursor L-Arg.
Systemic administration of L-NAME led to severe intestinal secretion associated with macroscopic and microscopic evidence of intestinal ischaemia with some areas of infarction. This is further evidence of the importance of NO in maintaining mesenteric circulation and thus intestinal mucosal integrity. Both intestinal ischaemia and intestinal secretion were markedly attenuated by pretreatment with L-Arg but not D-Arg, confirming the specificity of the effect. Our results are in accordance with those of Schirgi-Degen and Beubler,28 in that L-NAME given parenterally induced secretion in rat jejunum; we disagree, however, with their conclusion that NO is an absorbagogue as the L-NAME induced secretion in their experiments is most likely due to decreased blood flow.
Nitric oxide exerts its biological effects locally either as a paracrine mediator or as a neurotransmitter. We propose that within the intestine, inhibition of NO release in the vicinity of the vasculature causes ischaemia and consequent intestinal secretion, and that increased NO production in the vicinity of enterocytes also promotes intestinal secretion. The secretion induced by L-Arg perfusion is due to increased NO production in the vicinity of enterocytes. The secretion produced by subcutaneous administration of L-NAME is due to intestinal ischaemia. Secretion induced by perfusion with L-Arg is reversed by perfusion in combination with 0O1 mmolIl L-NAME owing to inhibition of NO production in the vicinity of the enterocytes. However, perfusion with higher concentrations of L-NAME paradoxically enhances L-Arg induced secretion by affecting the vasculature and producing ischaemia and consequent secretion. Thus there is a delicate balance between the effect of NO and inhibitors of NO on enterocyte and vascular function. In summary, L-Arg induces water and electrolyte secretion in the rat small intestine through an NO mediated mechanism due either to a direct effect on enterocytes or through neuronal activation. Intraluminal and systemic NOS inhibition leads to severe intestinal secretion by decreasing mesenteric blood flow resulting in intestinal ischaemia. There seems to be a fine balance between the prosecretory effect of NO on enterocytes or myenteric neurones and its role in maintaining blood flow and thus preventing intestinal ischaemia.
